TY  - CONF

T1  - Denosumab for the prevention of symptomatic skeletal events in patients with castration-resistant advanced prostate cancer: A comparison with skeletal-related events.

JO  - Journal of Clinical Oncology

PY  - 2014/02/01

AU  - Smith MR

AU  - Coleman RE

AU  - Klotz L

AU  - Pittman KB

AU  - Milecki P

AU  - Wei R

AU  - Balakumaran A

AU  - Fizazi K

ED  - 

DO  - DOI: 10.1200/jco.2014.32.4_suppl.35

PB  - American Society of Clinical Oncology (ASCO)

VL  - 32

IS  - 4_suppl

SP  - 35

EP  - 35

Y2  - 2025/10/10

ER  -